FIELD: medicine, pharmacy.
SUBSTANCE: invention refers to the compound of IIB formula, or its pharmaceutically acceptable salts in which R represents a bicyclic nine-membered heteroaryl comprising 1, 2, 3 or 4 heteroatoms independently selected from N, S or O, wherein the said heteroaryl may be substituted by one or more substituents selected from the group consisting of oxo and halo; R1 is -NHR4 and R4 is 3-10 membered cycloalkyl, aryl selected from phenyl and tetrahydronaphthalene, or 9-10 membered heteroaryl containing 1 or 2 heteroatoms selected from N and O; 3-10 membered cycloalkyl; aryl selected from phenyl and naphthalenyl; or 5-10-membered monocyclic or bicyclic heteroaryl comprising one or two heteroatoms selected from N, O and S; R2 and R3 are hydrogen; values of other substitutes are specified in the invention formula; or where the compound is selected from a group consisting of compounds specified in the invention formula. Invention compounds have properties of nicotinamide phosphoribosyltransferase (NAMPT) inhibitor. The invention also refers to individual compounds selected from the group indicated in the invention formula, to the pharmaceutical composition, method of treatment, compounds application and application of the pharmaceutical composition.
EFFECT: invention provides new compounds of IIB formula, with the properties of nicotinamide phosphoribosyltransferase inhibitor which can be used for hyperproliferative disorders treatment.
33 cl, 4 tbl, 25 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITING NAMPT | 2011 |
|
RU2617643C2 |
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITING NAMPT | 2011 |
|
RU2616612C2 |
NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITING NAMPT | 2011 |
|
RU2617424C2 |
GUANIDINE COMPOUNDS AND COMPOSITIONS FOR INHIBITING NAMPT | 2011 |
|
RU2593759C2 |
HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS | 2011 |
|
RU2586974C2 |
COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
PHOSPHOINOSITIDE-3-KINASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID INHIBITORS | 2007 |
|
RU2437888C2 |
NOVEL CONDENSED PYRIDINE DERIVATIVES USED AS C-MET TYROSINE KINASE INHIBITORS | 2013 |
|
RU2619130C2 |
CONDENSED DERIVATIVES OF AZOLPYRIMINE WITH INHIBITING PROPERTIES OF PHOSPHATIDYL INOSITOL-3-KINASE (PI3K) | 2003 |
|
RU2326881C9 |
Authors
Dates
2017-05-02—Published
2011-09-02—Filed